Press release
What Is Driving Global Liraglutide And Semaglutide Market Growth in 2025: The Role of Rising Diabetes Prevalence Drives Growth in Liraglutide and Semaglutide Markets
Liraglutide And Semaglutide Market
Liraglutide And Semaglutide Market Size Growth Forecast: What to Expect by 2025?
The market encompassing liraglutide and semaglutide has experienced substantial expansion lately, projected to increase from a valuation of $15.19 billion in 2024 to $16.94 billion in 2025, reflecting an annual growth rate of 11.5% based on the compound annual growth rate. This notable upward trend during the past period is fundamentally driven by a rising tide of diabetes diagnoses, the escalating occurrence of ailments linked to obesity, an increase in ongoing clinical investigation, greater financial commitment to exploring and developing diabetes treatments, and a greater consumer pull for easily administered therapeutic solutions.
How Will the Liraglutide And Semaglutide Market Size Evolve and Grow by 2029?
Anticipation surrounds the liraglutide and semaglutide sector, projecting substantial expansion over the coming years, ultimately reaching a valuation of $26.07 billion by 2029, propelled by an 11.4% compound annual growth rate. This surge throughout the projection timeframe is underpinned by several factors: greater utilization of GLP-1 receptor agonists, escalating spending within the healthcare domain, pharmaceutical firms broadening their offerings, upswings in personal disposable income, and a growing elderly demographic facing higher diabetes risks. Key developments anticipated during this period involve the incorporation of digital wellness systems, putting into practice tailored dosage regimens, progress in methods for administering medication, the creation of equivalent biosimilar products, and the incorporation of artificial intelligence to aid in treatment choices.
View the full report here:
https://www.thebusinessresearchcompany.com/report/liraglutide-and-semaglutide-global-market-report
What Drivers Are Propelling the Growth of Liraglutide And Semaglutide Market Forward?
Anticipated expansion in the liraglutide and semaglutide sectors is being fueled by the continually increasing global population grappling with diabetes, a persistent ailment defined by heightened blood glucose concentrations stemming from the body's inadequate insulin output or resistance to its effects; this escalation in diabetes cases can be attributed to factors such as inactive lifestyles, suboptimal eating patterns, and inherited susceptibilities, while liraglutide and semaglutide play a critical role in diabetes care by successfully regulating blood sugar and mitigating the potential for diabetes-related complications; for context, official figures released by the UK's National Health Service in June 2024 indicated that during 2023, the NHS registered more than half a million (549,000) new individuals across England identified as being at risk of type 2 diabetes, thereby increasing the cumulative count of people diagnosed with non-diabetic hyperglycemia, or pre-diabetes, on GP registers to 3,615,330, a notable year-over-year rise when compared to the 3,065,825 recorded in 2022, signifying an approximate 20 percent surge, underscoring how this growing diabetic patient pool acts as a major catalyst for the liraglutide and semaglutide markets.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18400&type=smp
Which Emerging Trends Are Transforming the Liraglutide And Semaglutide Market in 2025?
Major companies in the liraglutide and semaglutide markets are developing anti-diabetic biosimilar drugs to improve glucose regulation and lower cardiovascular risks in diabetic patients. These biosimilars are cost-effective, highly similar versions of original diabetes biologics designed to provide the same therapeutic benefits. For example, in January 2024, Glenmark Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced a biosimilar of the widely used anti-diabetic drug Liraglutide, marking its first launch in India. This biosimilar of Liraglutide helps enhance glycemic control in adults with type 2 diabetes mellitus. The launch aims to make treatment more affordable, reducing daily therapy costs and expanding access for patients across the country. Priced at around INR 100 for a 1.2 mg daily dose, it lowers therapy expenses by nearly 70% and is available only with a prescription.
What Are the Key Segments in the Liraglutide And Semaglutide Market?
The liraglutide and semaglutidemarket covered in this report is segmented -
1) By Type: Pills; Liquid
2) By Administration: Parenteral; Oral
3) By Application: Type 2 Diabetes Mellitus; Obesity; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Pills: Oral Tablets (Liraglutide, Semaglutide); Extended-Release Oral Formulations
2) By Liquid: Injectable Solutions (Liraglutide, Semaglutide); Pre-Filled Syringes; Vials For Injection
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18400&type=smp
Who Are the Key Players Shaping the Liraglutide And Semaglutide Market's Competitive Landscape?
Major companies operating in the liraglutide and semaglutide market are Pfizer Inc., Merck & Co. Inc., Bristol-Myers Squibb, AstraZeneca, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Pharma Co. Ltd., Shionogi & Co. Ltd., Cadila Pharmaceuticals, Kyowa Kirin Co. Ltd., Dr. Reddy's Laboratories Ltd., Biocon, Glenmark Pharmaceuticals Ltd., Bachem, Zealand Pharma, Shenzhen JYMed Technology Co. Ltd., Incepta Pharmaceuticals Ltd.
What Geographic Markets Are Powering Growth in the Liraglutide And Semaglutide Market?
North America was the largest region in the liraglutide and semaglutide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide and semaglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18400
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Is Driving Global Liraglutide And Semaglutide Market Growth in 2025: The Role of Rising Diabetes Prevalence Drives Growth in Liraglutide and Semaglutide Markets here
News-ID: 4277146 • Views: …
More Releases from The Business Research Company
Analysis of Key Market Segments Influencing the Extraterrestrial Legal Systems M …
Exploring the Future of Extraterrestrial Legal Systems
As humanity advances its presence beyond Earth, the need for specialized legal frameworks governing activities in outer space is becoming increasingly critical. The extraterrestrial legal systems market is set to expand rapidly, driven by the complexities of managing property rights, regulatory compliance, and dispute resolution in off-world environments. Let's delve into the anticipated market value, key players, significant trends, and the main segments shaping…
Emerging Growth Trends Driving Expansion in the Explosion Proof Cabins Market
The explosion proof cabins market is set to experience significant growth over the coming years, driven by increasing industrial safety demands and technological advancements. This market's evolution is shaped by emerging materials, innovative designs, and expanding applications, which all contribute to the rising adoption of explosion-resistant cabins in hazardous environments.
Forecast of the Explosion Proof Cabins Market Size by 2030
The explosion proof cabins market is projected to reach a value of…
Market Structure, Emerging Trends, and Key Player Analysis of the Electronic Pay …
The electronic payload fairing separation system market is poised for impressive expansion as innovations and technological advancements continue to reshape space launch operations. This report delves into the anticipated market size, key players, emerging trends, and segment classifications, offering a comprehensive overview of this specialized aerospace sector.
Projected Market Size and Growth Trajectory for Electronic Payload Fairing Separation Systems
The market for electronic payload fairing separation systems is forecasted to achieve substantial…
Leading Companies Fueling Growth and Innovation in the Dual Mode Microwave Seeke …
The dual mode microwave seeker market is positioned for significant expansion over the coming years, driven by a range of technological advancements and increasing defense requirements. This segment plays a crucial role in modern warfare and missile guidance, with innovation and integration shaping its future trajectory. Let's explore the current market size, key drivers, major players, and segmentation of this specialized industry.
Projected Market Growth for the Dual Mode Microwave Seeker…
More Releases for Liraglutide
Impact Of Diabetic Population Growth On The Liraglutide Market: Critical Driver …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liraglutide Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for liraglutide has seen substantial growth in recent years. The market size, which is expected to be at $6.38 billion in 2024, is projected to inflate to $6.95 billion in 2025, with a Compound…
Rising Diabetes Prevalence Drives Growth in Liraglutide and Semaglutide Markets …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Liraglutide And Semaglutide Industry Market Size Be by 2025?
In recent times, the liraglutide and semaglutide market has seen quick and impressive growth. The growth is projected to continue, with the market size increasing from $15.19 billion in 2024 to an estimated $16.98 billion in 2025,…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
What combination of drivers is leading to accelerated growth in the liraglutide market?
The increasing diabetic population is expected to propel the liraglutide market. Diabetes, particularly type 2, is on the rise due to factors like sedentary lifestyles, unhealthy diets, and obesity. Liraglutide, a drug that mimics the GLP-1 hormone to regulate blood sugar, plays a significant role in managing diabetes. In March 2023, the UK's NHS reported a rise in…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
"What Are the Projections for the Size and Growth Rate of the Liraglutide Market?
The market for liraglutide has seen robust expansion in the past few years. The market is projected to escalate from $6.38 billion in 2024 to $6.95 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This surge during the historic period can be linked to the rising numbers of individuals being identified with type…
Liraglutide Market Analysis 2024: Trends, Growth Drivers, and Key Players
"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!
The new report published by The Business Research Company, titled Liraglutide Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the liraglutide…
Global Liraglutide Market Top Companies in Liraglutide 2019 - HEC Pharm ,Teva ,B …
Researchreport.Biz Leading Research Firm has added the latest report on "Global Liraglutide Market by Manufacturers, Regions, Type, and Application, Forecast to 2024".
The purpose of "Global Liraglutide Market" report is to provide the newest industry data and Liraglutide industry future trends, allowing consumers to identify the Liraglutide market Application, Type, Manufacturers and Regions, Liraglutide market Forecast period 2019-2024.
The scope of Global Liraglutide Market Report:
2019 "Worldwide Liraglutide Market" lists the ruling vendors…
